NCT00917644
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Miami, Florida, United States
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
1,810 public trials
143 recruiting studies
Dyslipidemias trial results
NCT00150371
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Edmonton, Alberta, Canada
NCT00993915
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +10 more
- Locations
-
Not specified
NCT00163202
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Edmonton, Alberta, Canada
- Pfizer Investigational Site Vancouver, British Columbia, Canada
- Pfizer Investigational Site Winnipeg, Manitoba, Canada
NCT00141141
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site S. Benedetto DEL Tronto, Ascoli Piceno, Italy
- Pfizer Investigational Site S.Pietro Vernotico, Brindisi, Italy
- Pfizer Investigational Site Casarano, Lecce, Italy
- Pfizer Investigational Site Pavia, PV, Italy
NCT00163163
- Conditions
- Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site Afsnee GENT, Belgium
- Pfizer Investigational Site Assenede, Belgium
- Pfizer Investigational Site Brussels, Belgium
- Pfizer Investigational Site Brussels, Belgium
NCT00645424
- Conditions
- Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Pfizer Investigational Site Kaohsiung City, Taiwan
- Pfizer Investigational Site Kaohsiung Hsien, Taiwan
- Pfizer Investigational Site Taichung, Taiwan
- Pfizer Investigational Site Taipei, Taiwan
Completed
Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke
NCT00163150
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Pfizer Investigational Site Paris, France
NCT00758004
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
NCT00777517
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site Singapore